Skip to main content
SpringerLink
Log in
Book cover

Dietary Chinese Herbs pp 23–41Cite as

Food and Nutraceutical Applications of Chinese Herbal Products

  • Chapter
  • First Online:

  • 3149 Accesses

Abstract

Traditional Chinese medicine (TCM) is undergoing rapid growth and development in China and worldwide. Risks and benefits associated with Chinese herbal products, that are consumed as functional foods or nutraceuticals, requires further understanding before entering new markets including Canada.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Helmut Kaiser Consultancy (2013) Traditional Chinese Medicine (TCM) In China and Worldwide. Available at http://www.hkc22.com/ChineseMedicine.html. Accessed on 06 Aug 2013

  2. Nutrition Business Journal (2008) Integrative medicine stakeholders organize to address healthcare crisis integrative medicine is on the rise in the United States. Nutr Bus J XII 11:1–13

    Google Scholar 

  3. Nutrition Business Journal (2012) 2012 Supplement Business Report. Executive summary available at http://newhope360.com/site-files/newhope360.com/files/uploads/2013/04/TOCSUMM120928.supp%20report%20FINAL%20standard.pdf. Accessed on 08 Aug 2013

  4. National Center for Complementary and Alternative Medicine (2009) Traditional chinese medicine: An introduction. Available at http://nccam.nih.gov/health/whatiscam/chinesemed.htm#examples. Accessed on 22 Sept 2013

  5. Qian et al (2012) Effect of salvia miltiorrhiza hydrophilic extract on antioxidant enzymes in diabetic patients with chronic heart disease: a randomized controlled trial. Phytotherapy Res 26(1):60–66. doi:10.1002/ptr.3513

    Article  CAS  Google Scholar 

  6. Health Canada (2013) A new approach to natural health products. Available at: http://www.hc-sc.gc.ca/dhp-mps/prodnatur/nhp-new-nouvelle-psn-eng.php#fnb1-ref. Accessed on 05 Aug 2013

  7. Health Canada (2013) Harper Government Continues to Engage with Traditional Chinese Medicine Community in Canada. Available at: http://www.hc-sc.gc.ca/ahc-asc/media/nr-cp/_2013/2013-44-eng.php. Accessed on 05 Aug 2013

  8. Health Canada (2011) Natural Health Product Tracking Survey—2010 Final Report. Prepared by: Ipsos Reid. Available at http://epe.lac-bac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2011/135-09/report.pdf. Accessed on 21 Sept 2013

  9. Government of Canada (2003) Natural Health Products Regulations (SOR/2003-196), Canada Gazette Part II, vol 137, no 13. Available at http://publications.gc.ca/gazette/archives/p2/2003/2003-06-18/pdf/g2-13713.pdf. Accessed on 22 Sept 2013

  10. Quan et al (2008) Complementary and alternative medicine use among Chinese and white Canadians. Can Fam Physician 54(11):1563–1569. doi:10.54/11/1563 [pii]

    Google Scholar 

  11. Government of Canada (1985) Food and Drugs Act (R.S.C., 1985, c. F-27). Available at http://laws-lois.justice.gc.ca/eng/acts/F-27/page-14.html#h-21. Accessed on 22 Sept 2013

  12. Government of Canada (2007) Regulations Amending Schedule A to the Food and Drugs Act and the Medical Devices Regulations—Project 1539 (SOR/2007-288). Canada Gazette Part II, vol 141, no 26. Available at http://publications.gc.ca/gazette/archives/p2/2007/2007-12-26/pdf/g2-14126.pdf. Accessed on 22 Sept 2013

  13. U.S. Food and Drug Administration (2004) Botanical Drug Products. Guidance for Industry. Available at http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070491.pdf. Accessed on 22 Sept 2013

  14. The European Parliament and the Council of the European Union (2004) Directive 2004/24/EC of the European Parliament and of the Council of 31 March 2004 amending, as regards traditional herbal medicinal products. Official J Eur Union 47:85–90

    Google Scholar 

  15. European Medicines Agency (2013) The Committee on Herbal Medicinal Products Overview. Available at http://www.ema.europa.eu/ema/index.jsp?curl=pages/about_us/general/general_content_000122.jsp&mid=WC0b01ac0580028e7d. Accessed on 22 Sept 2013

  16. European Food Safety Authority (2012) Compendium of botanicals reported to contain naturally occuring substances of possible concern for human health when used in food and food supplements. EFSA J 10(5):2663

    Google Scholar 

  17. Collins (2011) A ten-year audit of traditional Chinese medicine and other natural product research published in the Chinese Medical Journal (2000–2009). Chin Med J 124(9):1401–1408. doi:10.3760/cma.j.issn.0366-6999.2011.09.023

    Google Scholar 

  18. Boik (ed) (1995) Cancer and natural medicine: a textbook of basic science and clinical research. Oregon Medical Press, Princeton

    Google Scholar 

  19. Wang et al (2006) Study on combination components and effectiveness of Chinese traditional herbal formulas. China J Chin Mat Med 31(1):5–9

    Google Scholar 

  20. Fong et al (2006) Evidence-based herbal medicine: challenges in efficacy and safety assessments. Curr Rev Chin Med 2:11–26. doi:10.1142/9789812774019_0002

    Article  Google Scholar 

  21. Zhu and Woerdenbag (1995) Traditional Chinese herbal medicine. Pharm World Sci 17(4):103–112. doi:10.1007/bf01872386

    Article  Google Scholar 

  22. Fong (2002) Integration of herbal medicine into modern medical practices: issues and prospects. Integr Cancer Ther 1(3):287–293

    Article  Google Scholar 

  23. Fitzloff et al (1998) Perspectives on the quality assurance of ginseng products in North America. In: Advances in Ginseng Research—Proceedings of the 7th International Symposium on Ginseng, Seoul, Korea

    Google Scholar 

  24. Gilroy et al (2003) Echinacea and truth in Labeling. Arch Intern Med 163(6):699–704. doi:10.1001/archinte.163.6.699

    Article  Google Scholar 

  25. Liva (2009) Controlled testing: the cornerstone of all quality natural products. Integr Med 8(2):40–42

    Google Scholar 

  26. Tang et al (2009) Modern understanding for “eighteen incompatible medicaments” and “nineteen medicaments of mutual restraint” in TCM. Chin J Exp Trad Med Formulae 15(6):79–82

    Google Scholar 

  27. Ulbricht et al (2008) Clinical evidence of herb-drug interactions: a systematic review by the natural standard research collaboration. Curr Drug Metab 9(10):1063–1120

    Article  CAS  Google Scholar 

  28. Zhou et al (2007) Identification of drugs that interact with herbs in drug development. Drug Discovery Today 12(15–16):664–673. doi:10.1016/j.drudis.2007.06.004

    Article  CAS  Google Scholar 

  29. Gagnier et al (2006) Recommendations for reporting randomized controlled trials of herbal interventions: explanation and elaboration. J Clin Epidemiol 59(11):1134–1149. doi:10.1016/j.jclinepi.2005.12.020

    Article  Google Scholar 

  30. Gagnier et al (2006) Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement. Ann Intern Med 144(5):364–367

    Article  Google Scholar 

  31. Liu et al (2013) Prospective registration, bias risk and outcome-reporting bias in randomised clinical trials of traditional Chinese medicine: an empirical methodological study. BMJ open 3(7):e002968. doi:10.1136/bmjopen-2013-002968

    Article  Google Scholar 

  32. Malla et al (2013) Assessing the functional foods and natural health products industry: a comparative overview and literature review. Canadian Agricultural Innovation and Regulation (CAIRN) Network. Available at http://www.ag-innovation.usask.ca/cairn_briefs/publications%20for%20download/Publication. Accessed on 30 Aug 2013

  33. Kaur, Das (2011) Functional foods: an overview. Food Sci Biotechnol 20(4):861–875. doi:10.1007/s10068-011-0121-7

    Article  Google Scholar 

  34. Evani (2009) Tendances du marché américain en matière d’aliments, de boissons et d’ingrédients fonctionnels. Institute of Food Technologists. Available at http://www.agrireseau.qc.ca/Marketing-Agroalimentaire/documents/Tendances%20aliments%20fonctionnels%20-%20USA%20-%20AAC%2007-2009.pdf. Accessed on 26 July 2013

  35. Cinnamon (2007) Results from the Functional Foods and Natural Health Products Survey -2007. Statistics Canada. Available at http://www.statcan.gc.ca/pub/88f0006x/88f0006x2009001-eng.htm. Accessed on 01 July 2013

  36. Stein AJ, Rodriguez-Cerezo E (2008) Functional Food in the European Union, Institute for Prospective Technological Studies (IPTS), Technical report series EUR 23380 EN-2008. Available at http://ftp.jrc.es/EURdoc/JRC43851.pdf. Accessed on 30 Aug 2013

  37. Trueman (2009) Functional foods. Patents and health claims, IP Strategist Publication, Nerac Inc

    Google Scholar 

  38. Vuong (2004) Obtaining a quantity of ripen fruits of Momordica cochinchinensis plant (spinyl melon), collecting aril and seeds from the cavity of the fruit, separating aril from the seeds, drying wet aril, extracting oil from the aril. Patent Publication number US20040024275 A1, Publication date 5 Feb 2004

    Google Scholar 

  39. Green R, Owusu-Ansah YJ (1999) Natural heat stable flavorings for bakery applications. Patent Publication number US5902622 A, Publication date 11 May 1999

    Google Scholar 

  40. Mennett et al (2004) The use of labiatae herb preparations for foam enhancement of beverages. Patent Publication number CA2538766 A1, Publication date 31 March 2005

    Google Scholar 

  41. Morazzoni et al (2005) Use of ginkgo complexes for the enhancement of cognitive functions and the alleviation of mental fatigue. Patent Publication number CA2554760 A1, Publication date 18 Aug 2005

    Google Scholar 

  42. Nielsen SVS, Teisen-Simony C (2011) Appetite regulating dietary supplement. Patent Publication number CA2781740 A1, Publication date 3 June 2011

    Google Scholar 

  43. Kong (2002) Fermented herbal drink. Patent Publication number CA2325751 A1, Publication date 2 May 2002

    Google Scholar 

  44. Adachi et al (2011) Flavor deterioration inhibitor and inhibitor for the generation of citral deterioration smell. Patent Publication number CA2489390 C, Publication date 19 July 2011

    Google Scholar 

  45. Health Canada (2013) Licensed natural health products database. Available at http://www.hc-sc.gc.ca/dhp-mps/prodnatur/applications/licen-prod/lnhpd-bdpsnh-eng.php]. Accessed on: 30 Aug 2013

  46. Carroll et al (2011) Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer Prevent Res 4(3):354–364. doi:10.1158/1940-6207.capr-10-0098

    Article  CAS  Google Scholar 

  47. Chuengsamarn et al (2012) Curcumin extract for prevention of type 2 diabetes. Diabetes Care 35(11):2121–2127. doi:10.2337/dc12-0116

    Article  CAS  Google Scholar 

  48. Khajehdehi et al (2011) Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-beta and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: a randomized, double-blind and placebo-controlled study. Scand J Urol Nephrol 45(5):365–370. doi:10.3109/00365599.2011.585622

    Article  CAS  Google Scholar 

  49. Mohammadi et al (2013) Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial. Phytotherapy Res 27(3):374–379. doi:10.1002/ptr.4715

    Article  CAS  Google Scholar 

  50. Rasyid, Lelo (1999) The effect of curcumin and placebo on human gall bladder function: an ultrasound study. Aliment Pharmacol Ther 13(2):245–249

    Article  CAS  Google Scholar 

  51. Satoskar et al (1986) Evaluation of antiinflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation. Int J Clin Pharmacol Ther 24(12):651–654

    CAS  Google Scholar 

  52. Wongcharoen et al (2012) Effects of curcuminoids on frequency of acute myocardial infarction after coronary artery bypass grafting. Am J Cardiol 110(1):40–44. doi:10.1016/j.amjcard.2012.02.043

    Article  CAS  Google Scholar 

  53. Albrecht et al (2004) Efficacy and safety of the platelet-activating factor receptor antagonist BN 52021 (Ginkgolide B) in patients with severe sepsis—a randomised, double-blind, placebo-controlled, multicentre trial. Clin Drug Investig 24(3):137–147. doi:10.2165/00044011-200424030-00002

    Article  CAS  Google Scholar 

  54. Brinkley et al (2010) Effect of ginkgo biloba on blood pressure and incidence of hypertension in elderly men and women. Am J Hypertens 23(5):528–533. doi:10.1038/ajh.2010.14

    Article  Google Scholar 

  55. Brochet et al (1995) Double blind placebo controlled multicentre study of ginkgolide B in treatment of acute exacerbations of multiple sclerosis. The ginkgolide study group in multiple sclerosis. J Neurol Neurosurg Psychiatry 58(3):360–362

    Article  CAS  Google Scholar 

  56. Oskouei et al (2013) The effect of ginkgo biloba on functional outcome of patients with acute ischemic stroke: a double-blind, placebo-controlled, randomized clinical trial. J Stroke Cerebrovas Dis 22(8):E557–E563. doi:10.1016/j.jstrokecerebrovasdis.2013.06.010

    Article  Google Scholar 

  57. Vellas et al (2012) Long-term use of standardised ginkgo biloba extract for the prevention of alzheimer’s disease (GuidAge): a randomised placebo-controlled trial. Lancet Neurol 11(10):851–859. doi:10.1016/s1474-4422(12)70206-5

    Article  CAS  Google Scholar 

  58. Zhang et al (2013) Ginkgo biloba extract for patients with early diabetic nephropathy: a systematic review. Evid Based Complement Altern Med eCAM 2013:689142–689142. doi:10.1155/2013/689142

    Google Scholar 

  59. Zhao et al (2012) Effects of ginkgo biloba extract in improving episodic memory of patients with mild cognitive impairment: a randomized controlled trial. J Chin Integr Med 10(6):628–634

    Article  Google Scholar 

  60. Khan et al (2003) Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care 26(12):3215–3218. doi:10.2337/diacare.26.12.3215

    Article  Google Scholar 

  61. Leach MJ and Kumar S (2012) Cinnamon for diabetes mellitus. Cochrane Database Syst Rev 9. doi:10.1002/14651858.CD007170.pub2

  62. Mang et al (2006) Effects of a cinnamon extract on plasma glucose, HbA(1c), and serum lipids in diabetes mellitus type 2. Eur J Clin Invest 36(5):340–344. doi:10.1111/j.1365-2362.2006.01629.x

    Article  CAS  Google Scholar 

  63. Vanschoonbeek et al (2006) Cinnamon supplementation does not improve glycemic control in postmenopausal type 2 diabetes patients. J Nutr 136(4):977–980. doi:10.136/4/977 [pii]

    CAS  Google Scholar 

  64. de Andrade et al (2007) Study of the efficacy of Korean red ginseng in the treatment of erectile dysfunction. Asian J Androl 9(2):241–244. doi:10.1111/j.1745-7262.2007.00210.x

    Article  Google Scholar 

  65. Hong et al (2002) A double-blind crossover study evaluating the efficacy of Korean red ginseng in patients with erectile dysfunction: a preliminary report. J Urol 168(5):2070–2073. doi:10.1097/01.ju.0000034387.21441.87

    Article  CAS  Google Scholar 

  66. Liu et al (2012) Ginsenoside-Rd improves outcome of acute ischaemic stroke—a randomized, double-blind, placebo-controlled, multicenter trial. Eur J Neurol 19(6):855–863. doi:10.1111/j.1468-1331.2011.03634.x

    Article  CAS  Google Scholar 

  67. Scholey et al (2010) Effects of American ginseng (Panax quinquefolius) on neurocognitive function: an acute, randomised, double-blind, placebo-controlled, crossover study. Psychopharmacology 212(3):345–356. doi:10.1007/s00213-010-1964-y

    Article  CAS  Google Scholar 

  68. Vuksan et al (2008) Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: Results of a randomized, double-blind, placebo-controlled study of efficacy and safety. Nutr Metab Cardiovasc Dis 18(1):46–56. doi:10.1016/j.numecd.2006.04.003

    Article  Google Scholar 

  69. Ziemba et al (1999) Ginseng treatment improves psychomotor performance at rest and during graded exercise in young athletes. Int J Sport Nutr 9(4):371–377

    CAS  Google Scholar 

  70. Alizadeh-Navaei et al (2008) Investigation of the effect of ginger on the lipid levels a double blind controlled clinical trial. Saudi Med J 29(9):1280–1284

    Google Scholar 

  71. Zick et al (2009) Phase II trial of encapsulated ginger as a treatment for chemotherapy-induced nausea and vomiting. Support Care Cancer 17(5):563–572. doi:10.1007/s00520-008-0528-8

    Article  Google Scholar 

  72. Yang et al (2012) A randomized, double-blind, placebo-controlled study to evaluate the efficacy and tolerability of Fufang Danshen (salvia miltiorrhiza) as add-on antihypertensive therapy in taiwanese patients with uncontrolled hypertension. Phytotherapy Res 26(2):291–298. doi:10.1002/ptr.3548

    Article  Google Scholar 

  73. Kimura et al (2007) Food-grade mulberry powder enriched with 1-deoxynojirimycin suppresses the elevation of postprandial blood glucose in humans. J Agric Food Chem 55(14):5869–5874. doi:10.1021/jf062680g

    Article  CAS  Google Scholar 

  74. Alvin et al (2011) A comparative study of the safety and efficacy of 75 % mulberry (morus alba) extract oil versus placebo as a topical treatment for melasma: a randomized, single-blind, placebo-controlled trial. J Drugs Dermatol 10(9):1025–1031

    CAS  Google Scholar 

  75. Chen CC et al (2012) Chinese herb astragalus membranaceus enhances recovery of hemorrhagic stroke: double-blind, placebo-controlled, randomized study. Evidence-Based Complementary and Alternative Medicine. doi: 10.1155/2012/708452

  76. Matkovic et al (2010) Efficacy and safety of astragalus membranaceus in the treatment of patients with seasonal allergic rhinitis. Phytotherapy Res 24(2):175–181. doi:10.1002/ptr.2877

    Google Scholar 

  77. Chen et al (2012) A novel infusible botanically-derived drug, PG2, for cancer-related fatigue: a phase II double-blind, randomized placebo-controlled study. Clin Invest Med 35(1):E1–E11

    CAS  Google Scholar 

  78. Al-Bareeq et al (2010) Dong Quai (Angelica sinensis) in the treatment of hot flashes for men on androgen deprivation therapy: results of a randomized double-blind placebo controlled trial. Cuaj-Can Urol Assoc J 4(1):49–53

    Google Scholar 

  79. Hirata et al (1997) Does dong quai have estrogenic effects in postmenopausal women? A double-blind, placebo-controlled trial. Fertil Steril 68(6):981–986

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Applied Human Nutrition, Mount Saint Vincent University, Halifax, NS, Canada

    Priya Kathirvel, Phillip Joy & Bohdan L. Luhovyy

Authors
  1. Priya Kathirvel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Phillip Joy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bohdan L. Luhovyy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bohdan L. Luhovyy .

Editor information

Editors and Affiliations

  1. Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China

    Yanze Liu

  2. Inst. of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China

    Zhimin Wang

  3. Aquatic and Crop Resource Development, National Research Council of Canada, Halifax, Canada

    Junzeng Zhang

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Wien

About this chapter

Cite this chapter

Kathirvel, P., Joy, P., Luhovyy, B.L. (2015). Food and Nutraceutical Applications of Chinese Herbal Products. In: Liu, Y., Wang, Z., Zhang, J. (eds) Dietary Chinese Herbs. Springer, Vienna. https://doi.org/10.1007/978-3-211-99448-1_2

Download citation

Publish with us

Policies and ethics

Search

Navigation